Page last updated: 2024-09-04

disufenton sodium and deamino arginine vasopressin

disufenton sodium has been researched along with deamino arginine vasopressin in 1 studies

Compound Research Comparison

Studies (disufenton sodium)	Trials (disufenton sodium)	Recent Studies (post-2010) (disufenton sodium)	Studies (deamino arginine vasopressin)	Trials (deamino arginine vasopressin)	Recent Studies (post-2010) (deamino arginine vasopressin)
114	19	15	4,396	516	1,016

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, YF; Egberg, N; Englund, G; Nilsson, D; Reinholdsson, I; Schulman, S; Wemer, J	1

Trials

1 trial(s) available for disufenton sodium and deamino arginine vasopressin

Article	Year
NXY-059 does not affect bleeding time in healthy volunteers: a randomized, double-blind, placebo-controlled, 3-period crossover phase I study. Journal of clinical pharmacology, 2007, Volume: 47, Issue:2 Topics: Benzenesulfonates; Bleeding Time; Blood Coagulation; Cross-Over Studies; Deamino Arginine Vasopressin; Double-Blind Method; Hemostatics; Humans; Male; Neuroprotective Agents; Platelet Adhesiveness; Platelet Aggregation	2007

Article

Year

NXY-059 does not affect bleeding time in healthy volunteers: a randomized, double-blind, placebo-controlled, 3-period crossover phase I study.

Journal of clinical pharmacology, 2007, Volume: 47, Issue:2

Topics: Benzenesulfonates; Bleeding Time; Blood Coagulation; Cross-Over Studies; Deamino Arginine Vasopressin; Double-Blind Method; Hemostatics; Humans; Male; Neuroprotective Agents; Platelet Adhesiveness; Platelet Aggregation

2007